We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.6M
Cap. Flow %
4.55%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
789
Reduced
1,481
Closed
1,566

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$213M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$157M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$63.3M
4
UWM icon
ProShares Ultra Russell2000
UWM
+$20.4M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$19.6M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.65%
2 Technology 1.48%
3 Materials 1.36%
4 Healthcare 1.28%
5 Industrials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAN.A
2576
DELISTED
The Aaron's Company Inc Class A
AAN.A
$3K ﹤0.01%
100
-2,290
-96% -$68.7K
ABEO icon
2577
Abeona Therapeutics
ABEO
$393M
$2K ﹤0.01%
20
-85
-81% -$11K
ACTG icon
2578
Acacia Research
ACTG
$451M
$2K ﹤0.01%
326
-172
-35% -$1K
AIRT icon
2579
Air T
AIRT
$92.2M
$2K ﹤0.01%
+132
New +$1.9K
ALDX icon
2580
Aldeyra Therapeutics
ALDX
$95.9M
$2K ﹤0.01%
360
-3,400
-90% -$17.5K
ALGN icon
2581
Align Technology
ALGN
$12.1B
$2K ﹤0.01%
17
-133
-89% -$13.4K
OSG
2582
Octave Specialty Group
OSG
$255M
$2K ﹤0.01%
107
-151
-59% -$3.18K
AQMS icon
2583
Aqua Metals
AQMS
$9.53M
$2K ﹤0.01%
1
-6
-86% -$18.7K
ARCB icon
2584
ArcBest
ARCB
$3.02B
$2K ﹤0.01%
58
-201
-78% -$5.9K
ARGT icon
2585
Global X MSCI Argentina ETF
ARGT
$822M
$2K ﹤0.01%
+61
New +$1.6K
ATEX icon
2586
Anterix
ATEX
$1.96B
$2K ﹤0.01%
99
-191
-66% -$4.32K
ATXS
2587
DELISTED
Astria Therapeutics
ATXS
$2K ﹤0.01%
22
-2
-8% -$275
AUBN icon
2588
Auburn National Bancorp
AUBN
$92.2M
$2K ﹤0.01%
+51
New +$1.65K
AVDL
2589
DELISTED
Avadel Pharmaceuticals
AVDL
$2K ﹤0.01%
257
-497
-66% -$4.97K
AXON
2590
Axon Enterprise
AXON
$42.1B
$2K ﹤0.01%
99
-2,133
-96% -$52.4K
BAK icon
2591
Braskem
BAK
$928M
$2K ﹤0.01%
100
-1,171
-92% -$24.6K
BFH icon
2592
Bread Financial
BFH
$4.44B
$2K ﹤0.01%
11
-1,085
-99% -$205K
BKF icon
2593
iShares MSCI BIC ETF
BKF
$78.1M
$2K ﹤0.01%
+50
New +$1.75K
BMRC icon
2594
Bank of Marin Bancorp
BMRC
$465M
$2K ﹤0.01%
+60
New +$2.04K
BOTJ icon
2595
Bank Of The James
BOTJ
$123M
$2K ﹤0.01%
+158
New +$2.22K
BOX icon
2596
Box
BOX
$4.41B
$2K ﹤0.01%
126
-74
-37% -$1.25K
BYD icon
2597
Boyd Gaming
BYD
$6.11B
$2K ﹤0.01%
96
-2,827
-97% -$57.4K
CATO icon
2598
Cato Corp
CATO
$65.9M
$2K ﹤0.01%
70
-1,142
-94% -$28.5K
CBAN icon
2599
Colony Bankcorp
CBAN
$468M
$2K ﹤0.01%
+121
New +$1.67K
CIEN icon
2600
Ciena
CIEN
$57.2B
$2K ﹤0.01%
100
-619
-86% -$15.2K
102 103
104
105 106

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.6M of net new capital in Q1 2017, opening 814 new positions and adding to 789 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.